1.Radiation-associated sarcomas of bone and soft tissue: a clinicopathological analysis of 46 cases.
L H GONG ; W F LIU ; L LI ; X Q SUN ; M ZHANG ; Y DING
Chinese Journal of Pathology 2023;52(10):995-1000
Objective: To investigate the clinical, imaging, histological, and molecular features and the differential diagnosis of radiation-associated sarcomas of bone and soft tissue. Methods: Forty-six cases of radiation-associated sarcomas of the bone and soft tissue in Beijing Jishuitan Hospital from January 2010 to January 2022 were retrospectively analyzed; and the imaging, histological features and immunophenotype were examined. Results: There were 33 females and 13 males, aged from 18 to 74 years, with a mean of 52 years. The most common site of radiation-associated sarcomas were the limbs and spine (15 cases), followed by the chest (9 cases). The primary diseases included epithelial tumors (15 breast cancer, 6 cervical cancer, and 5 bowel cancer), hematolymphoid tumors, bone and soft tissue tumors and infectious lesions. The latent period of radiation-associated sarcomas ranged from 2-22 years, with an average of 11.6 years. Histopathologically, the morphology was divergent from the primary tumor. The most common malignant tumor type was undifferentiated sarcoma (22 cases), followed by osteosarcoma (16 cases). The immunophenotype of radiation-related sarcoma was almost the same as the corresponding soft tissue sarcoma. Conclusions: Radiation-induced sarcoma has a wide range of primary tumor types and its imaging, morphology and immunohistochemical features are similar to those of the primary sarcoma of bone and soft tissue. Clinical correlation is often recommended for the differential diagnosis.
Male
;
Female
;
Humans
;
Retrospective Studies
;
Sarcoma/pathology*
;
Osteosarcoma/diagnostic imaging*
;
Soft Tissue Neoplasms/pathology*
;
Bone Neoplasms/pathology*
5.Progress in diagnosis of bone metastasis of prostate cancer.
Jun LIU ; Yongchao DONG ; Dongbo XU ; Chunlei ZHANG ; Tian LAN ; Dehui CHANG
Journal of Central South University(Medical Sciences) 2021;46(10):1147-1152
The diagnosis of bone metastasis of prostate cancer (PC) is of great significance to the treatment and prognosis of patients with PC.Bone scan is the most commonly used in the early diagnosis of bone metastasis, but its specificity is low and there is a high false positive.In recent years, with the in-depth study of the application of CT, MRI, emission computed tomography (ECT), positron emission computed tomography/computed tomography (PET/CT) and deep learning algorithm-convolutional neural networks (CNN) in the diagnosis of bone metastasis, the combined application of various auxiliary parameters in the diagnosis of bone metastasis has significantly been improved. The therapeutic effect of PC patients with bone metastasis can also be evaluated, which is expected to achieve the treatment of bone metastasis as well as diagnosis. By systematically expounding the research progress of the above-mentioned techniques in the diagnosis of bone metastasis, it can provide clinicians with new methods for the diagnosis of bone metastasis and improve the diagnostic efficiency for bone metastasis.
Bone Marrow Diseases
;
Bone Neoplasms/diagnostic imaging*
;
Humans
;
Magnetic Resonance Imaging
;
Male
;
Positron Emission Tomography Computed Tomography
;
Prostatic Neoplasms/diagnostic imaging*
6.Intraosseous Hibernoma: A Rare and Unique Intraosseous Lesion.
Boram SONG ; Hye Jin RYU ; Cheol LEE ; Kyung Chul MOON
Journal of Pathology and Translational Medicine 2017;51(5):499-504
BACKGROUND: Hibernoma is a rare benign tumor of adults that is composed of multivacuolated adipocytes resembling brown fat cells. Hibernoma typically occurs in soft tissue, and intraosseous examples are very rare. Intraosseous hibernomas can radiologically mimic metastatic carcinoma and other tumorous conditions. METHODS: To collect the intraosseous hibernomas, we searched the pathologic database and reviewed the hematoxylin and eosin (H&E)–stained slides of bone biopsy samples performed to differentiate radiologically abnormal bone lesions from 2006 to 2016. A total of six intraosseous hibernoma cases were collected, and clinical and radiological information was verified from electronic medical records. H&E slide review and immunohistochemical staining for CD68, pan-cytokeratin, and S-100 protein were performed. RESULTS: Magnetic resonance imaging of intraosseous hibernomas showed low signal intensity with slightly hyperintense foci on T1 and intermediate to high signal intensity on T2 weighted images. Intraosseous hibernomas appeared as heterogeneous sclerotic lesions with trabecular thickening on computed tomography scans and revealed mild hypermetabolism on positron emission tomography scans. Histopathologically, the bone marrow space was replaced by sheets of multivacuolated, foamy adipocytes resembling brown fat cells, without destruction of bone trabeculae. In immunohistochemical analysis, the tumor cells were negative for CD68 and pan-cytokeratin and positive for S-100 protein. CONCLUSIONS: Intraosseous hibernoma is very rare. This tumor can be overlooked due to its rarity and resemblance to bone marrow fat. Pathologists need to be aware of this entity to avoid misdiagnosis of this rare lesion.
Adipocytes
;
Adipocytes, Brown
;
Adult
;
Biopsy
;
Bone Marrow
;
Bone Neoplasms
;
Diagnostic Errors
;
Electronic Health Records
;
Eosine Yellowish-(YS)
;
Hematoxylin
;
Humans
;
Immunohistochemistry
;
Lipoma*
;
Magnetic Resonance Imaging
;
Pathology
;
Positron-Emission Tomography
;
S100 Proteins
7."Do Not Touch": An Uncommon Benign Fatty Bone Tumour.
Sumer N SHIKHARE ; Wilfred Cg PEH
Annals of the Academy of Medicine, Singapore 2016;45(9):427-429
Adult
;
Bone Neoplasms
;
diagnosis
;
diagnostic imaging
;
pathology
;
Diagnosis, Differential
;
Diaphyses
;
diagnostic imaging
;
pathology
;
Humans
;
Knee Joint
;
diagnostic imaging
;
pathology
;
Lipoma
;
diagnosis
;
diagnostic imaging
;
pathology
;
Magnetic Resonance Imaging
;
Male
;
Radiography
;
Tibia
;
diagnostic imaging
;
pathology
8.Peripheral Osteoma of Palate.
Manas BAJPAI ; Deshant AGARWAL ; Manish KUMAR ; Malay KUMAR
Annals of the Academy of Medicine, Singapore 2016;45(3):110-112
Bone Neoplasms
;
diagnostic imaging
;
pathology
;
Female
;
Humans
;
Middle Aged
;
Osteoma
;
diagnostic imaging
;
pathology
;
Palate
;
diagnostic imaging
;
pathology
;
Radiography
9.Advances in diagnosis and treatment of metastatic cervical cancer.
Haoran LI ; Xiaohua WU ; Xi CHENG
Journal of Gynecologic Oncology 2016;27(4):e43-
Cervical cancer is one of the most common cancers in women worldwide. The outcome of patients with metastatic cervical cancer is poor. We reviewed the relevant literature concerning the treatment and diagnosis of metastatic cervical cancer. There are two types of metastasis related to different treatments and survival rates: hematogenous metastasis and lymphatic metastasis. Patients with hematogenous metastasis have a higher risk of death than those with lymphatic metastasis. In terms of diagnosis, fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) and PET-computed tomography are effective tools for the evaluation of distant metastasis. Concurrent chemoradiotherapy and subsequent chemotherapy are well-tolerated and efficient for lymphatic metastasis. As for lung metastasis, chemotherapy and/or surgery are valuable treatments for resistant, recurrent metastatic cervical cancer and chemoradiotherapy may be the optimal choice for stage IVB cervical cancer. Chemotherapy and bone irradiation are promising for bone metastasis. A better survival is achieved with multimodal therapy. Craniotomy or stereotactic radiosurgery is an optimal choice combined with radiotherapy for solitary brain metastases. Chemotherapy and palliative brain radiation may be considered for multiple brain metastases and other organ metastases.
Bone Neoplasms/secondary/therapy
;
Brain Neoplasms/secondary/therapy
;
Chemoradiotherapy
;
Female
;
Fluorodeoxyglucose F18
;
Humans
;
Lung Neoplasms/secondary/therapy
;
Lymphatic Metastasis
;
Positron-Emission Tomography
;
Uterine Cervical Neoplasms/diagnostic imaging/*pathology/therapy
10.Advances in diagnosis and treatment of metastatic cervical cancer.
Haoran LI ; Xiaohua WU ; Xi CHENG
Journal of Gynecologic Oncology 2016;27(4):e43-
Cervical cancer is one of the most common cancers in women worldwide. The outcome of patients with metastatic cervical cancer is poor. We reviewed the relevant literature concerning the treatment and diagnosis of metastatic cervical cancer. There are two types of metastasis related to different treatments and survival rates: hematogenous metastasis and lymphatic metastasis. Patients with hematogenous metastasis have a higher risk of death than those with lymphatic metastasis. In terms of diagnosis, fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) and PET-computed tomography are effective tools for the evaluation of distant metastasis. Concurrent chemoradiotherapy and subsequent chemotherapy are well-tolerated and efficient for lymphatic metastasis. As for lung metastasis, chemotherapy and/or surgery are valuable treatments for resistant, recurrent metastatic cervical cancer and chemoradiotherapy may be the optimal choice for stage IVB cervical cancer. Chemotherapy and bone irradiation are promising for bone metastasis. A better survival is achieved with multimodal therapy. Craniotomy or stereotactic radiosurgery is an optimal choice combined with radiotherapy for solitary brain metastases. Chemotherapy and palliative brain radiation may be considered for multiple brain metastases and other organ metastases.
Bone Neoplasms/secondary/therapy
;
Brain Neoplasms/secondary/therapy
;
Chemoradiotherapy
;
Female
;
Fluorodeoxyglucose F18
;
Humans
;
Lung Neoplasms/secondary/therapy
;
Lymphatic Metastasis
;
Positron-Emission Tomography
;
Uterine Cervical Neoplasms/diagnostic imaging/*pathology/therapy

Result Analysis
Print
Save
E-mail